I was diagnosed with MSA by my neurologist at the Neurology Clinic at the University of Massachusetts Medical Center in October, 2003. I had symptoms in the previous year and maybe earlier. The diagnosis was confirmed with a tilt table test at the UMass Medical School where I participated in the research trial of Droxidopa. I later presented my experience with Droxidopa before an FDA panel in February 2012 while standing and in February 2014 from a wheelchair when it was finally approved. In the following year, 2015, we moved from Massachusetts to Independent Living in Florida where my husband remains as my caregiver.